Literature DB >> 21666459

Prevention of hospital-acquired legionellosis.

Yusen E Lin1, Janet E Stout, Victor L Yu.   

Abstract

PURPOSE OF REVIEW: The incidence of hospital-acquired legionellosis appears to be increasing. Presence of Legionella in the hospital drinking water is the only risk factor known with certainty to be predictive of risk for contracting Legionnaires' disease. RECENT
FINDINGS: Given the high frequency of infection by nonpneumophila and nonserogroup 1 species, both Legionella respiratory culture on selective media and urine antigen testing should be available in the hospital clinical microbiology laboratory. If the drinking water is contaminated by nonpneumophila or nonserogroup 1 species, Legionella culture on selective media must be available for patients with hospital-acquired pneumonia. The impact of PCR application for environmental water specimen remains to be elucidated. Its advantage is that it is a rapid test and its weakness is its low specificity. Copper-silver ionization disinfection and point-of-use (POU) filters have proved effective. Chlorine dioxide and monochloramine are under evaluation and their ultimate role remains to be elucidated. Routine Legionella cultures in concert with disinfectant levels are the best indicators for ensuring long-term efficacy. Percentage distal site positivity for Legionella in drinking water is accurate in predicting risk. Quantitative criteria (CFU/ml) have proven inaccurate and should be abandoned.
SUMMARY: Infection control professionals, not healthcare facility personnel or engineers, should play the leadership role in selecting and evaluating the specific disinfection modality. Proactive measures of routine environmental cultures for hospital water and disinfection modalities allow for effective prevention of this high-profile hospital-acquired infection.

Entities:  

Mesh:

Year:  2011        PMID: 21666459     DOI: 10.1097/QCO.0b013e3283486c6e

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  7 in total

1.  Environmental surveillance and molecular epidemiology of waterborne pathogen Legionella pneumophila in health-care facilities of Northeastern Greece: a 4-year survey.

Authors:  Ioanna G Alexandropoulou; Spyridon Ntougias; Theocharis G Konstantinidis; Theodoros A Parasidis; Maria Panopoulou; Theodoros C Constantinidis
Journal:  Environ Sci Pollut Res Int       Date:  2015-02-25       Impact factor: 4.223

2.  Structure of the WipA protein reveals a novel tyrosine protein phosphatase effector from Legionella pneumophila.

Authors:  Nikos Pinotsis; Gabriel Waksman
Journal:  J Biol Chem       Date:  2017-04-07       Impact factor: 5.157

3.  Preventing Healthcare-Associated Legionellosis: Results after 3 Years of Continuous Disinfection of Hot Water with Monochloramine and an Effective Water Safety Plan.

Authors:  Maria Anna Coniglio; Margherita Ferrante; Mohamed H Yassin
Journal:  Int J Environ Res Public Health       Date:  2018-07-27       Impact factor: 3.390

4.  A Proactive Environmental Approach for Preventing Legionellosis in Infants: Water Sampling and Antibiotic Resistance Monitoring, a 3-Years Survey Program.

Authors:  Ioanna Alexandropoulou; Theodoros Parasidis; Theocharis Konstantinidis; Maria Panopoulou; Theodoros C Constantinidis
Journal:  Healthcare (Basel)       Date:  2019-03-08

5.  Density-dependent resistance protects Legionella pneumophila from its own antimicrobial metabolite, HGA.

Authors:  Tera C Levin; Brian P Goldspiel; Harmit S Malik
Journal:  Elife       Date:  2019-05-28       Impact factor: 8.140

6.  Effect of Common Drinking Water Disinfectants, Chlorine and Heat, on Free Legionella and Amoebae-Associated Legionella.

Authors:  Sílvia Cervero-Aragó; Sarah Rodríguez-Martínez; Antoni Puertas-Bennasar; Rosa M Araujo
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

7.  Seeding and Establishment of Legionella pneumophila in Hospitals: Implications for Genomic Investigations of Nosocomial Legionnaires' Disease.

Authors:  Sophia David; Baharak Afshar; Massimo Mentasti; Christophe Ginevra; Isabelle Podglajen; Simon R Harris; Victoria J Chalker; Sophie Jarraud; Timothy G Harrison; Julian Parkhill
Journal:  Clin Infect Dis       Date:  2017-05-01       Impact factor: 20.999

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.